Bisoprololo Sandoz 2.5 mg

Bisoprololo Sandoz is a generic pharmaceutical product used primarily for treating hypertension and heart-related conditions. The brand Sandoz has a deep history, originating in Switzerland in the 19th century as a chemical company that later pivoted to pharmaceuticals.

While the packaging shown indicates it was once 'A Novartis Division', Sandoz successfully completed a spin-off from Novartis in October 2023. It is now an independent, publicly traded company. Manufacturing for such generic medications typically occurs across various global sites in Europe and Asia to meet international demand.

As of 2024 and moving forward, Sandoz Group AG operates as its own ultimate owner, headquartered in Switzerland, focusing exclusively on generic medicines and biosimilars.